Patients deserve access to innovative medicines — and the rigorous research needed to establish that those medicines are safe and effective.
The U.S. Department of Health and Human Services (HHS) is moving to ease restrictions on six experimental peptides. Peptides have been described as “building blocks of proteins,” playing “key roles for health.”
There’s just one problem. The department’s own scientists from the Food and Drug Administration (FDA) unanimously recommended against adding any of them to the list of substances eligible for drug compounding. But an FDA advisory committee composed of outside experts narrowly recommended allowing all six anyway.
It’s a troubling proposal that could put patients at risk — and discourage the costly research that has made America a global leader in pharmaceutical innovation. Peptides themselves are nothing new. These short chains of amino acids occur naturally throughout the body, performing a variety of essential functions.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
HHS Threatens Key Health Player Peptides, Innovation, and Patients
Sally C. Pipes
Patients deserve access to innovative medicines — and the rigorous research needed to establish that those medicines are safe and effective.
The U.S. Department of Health and Human Services (HHS) is moving to ease restrictions on six experimental peptides. Peptides have been described as “building blocks of proteins,” playing “key roles for health.”
There’s just one problem. The department’s own scientists from the Food and Drug Administration (FDA) unanimously recommended against adding any of them to the list of substances eligible for drug compounding. But an FDA advisory committee composed of outside experts narrowly recommended allowing all six anyway.
It’s a troubling proposal that could put patients at risk — and discourage the costly research that has made America a global leader in pharmaceutical innovation. Peptides themselves are nothing new. These short chains of amino acids occur naturally throughout the body, performing a variety of essential functions.
Read the op-ed here.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.